Shares of Oxford BioMedica plc (LON:OXB) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $660.79 and traded as high as $610.00. Oxford BioMedica shares last traded at $610.00, with a volume of 62,924 shares.
Several research analysts have weighed in on OXB shares. Peel Hunt reissued a “buy” rating on shares of Oxford BioMedica in a report on Wednesday, June 26th. Peel Hunt reissued a “buy” rating on shares of Oxford BioMedica in a report on Monday, September 2nd.
The stock’s 50-day moving average price is GBX 657.52 and its 200-day moving average price is GBX 689.11. The company has a current ratio of 2.44, a quick ratio of 2.26 and a debt-to-equity ratio of 118.46. The company has a market capitalization of $423.76 million and a P/E ratio of 50.64.
Oxford BioMedica Company Profile (LON:OXB)
Oxford BioMedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of lentiviral vector and cell therapy products for the treatment of various cancers, Parkinson's, central nervous system disorders, and ocular conditions in Europe and internationally. The company operates through Platform and Product segments.
Recommended Story: What is the formula for calculating total return?
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.